TCL Archive NCI Decides To Accept NCAB Recommendation, Award Organ Systems Coordinating Center to Roswell Park July 6, 1984
TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003
TCL Archive Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL July 11, 2014